BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

686 related articles for article (PubMed ID: 10727983)

  • 21. Antigenic profiles of individual-matched pairs of primary and melanoma metastases.
    Meije CB; Swart GW; Lepoole C; Das PK; Van den Oord JJ
    Hum Pathol; 2009 Oct; 40(10):1399-407. PubMed ID: 19386352
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Minichromosome maintenance protein expression in benign nevi, dysplastic nevi, melanoma, and cutaneous melanoma metastases.
    Boyd AS; Shakhtour B; Shyr Y
    J Am Acad Dermatol; 2008 May; 58(5):750-4. PubMed ID: 18249467
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adhesion molecule profile and malignancy of melanocytic lesions.
    Moretti S; Martini L; Berti E; Pinzi C; Giannotti B
    Melanoma Res; 1993 Aug; 3(4):235-9. PubMed ID: 8219755
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytoplasmic beta-catenin is lacking in a subset of melanoma-associated naevi, but is detectable in naevus-associated melanomas: potential implications for melanoma tumorigenesis?
    De Panfilis G; Ferrari D; Santoro S; Ricci R; Lombardi M; Pedrazzi G; Pepe C; Cortelazzi C; Santini M
    Br J Dermatol; 2009 Mar; 160(3):600-8. PubMed ID: 19183173
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oestrogen receptor-beta expression in melanocytic lesions.
    Schmidt AN; Nanney LB; Boyd AS; King LE; Ellis DL
    Exp Dermatol; 2006 Dec; 15(12):971-80. PubMed ID: 17083364
    [TBL] [Abstract][Full Text] [Related]  

  • 26. E-cadherin/catenin complex in benign and malignant melanocytic lesions.
    Silye R; Karayiannakis AJ; Syrigos KN; Poole S; van Noorden S; Batchelor W; Regele H; Sega W; Boesmueller H; Krausz T; Pignatelli M
    J Pathol; 1998 Dec; 186(4):350-5. PubMed ID: 10209482
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Accurate identification of proliferative index in melanocytic neoplasms with Melan-A/Ki-67 double stain.
    Puri PK; Valdes CL; Burchette JL; Grichnik JM; Turner JW; Selim MA
    J Cutan Pathol; 2010 Sep; 37(9):1010-2. PubMed ID: 20002650
    [No Abstract]   [Full Text] [Related]  

  • 28. Expression of neurotrophins and their receptors in pigment cell lesions of the skin.
    Innominato PF; Libbrecht L; van den Oord JJ
    J Pathol; 2001 May; 194(1):95-100. PubMed ID: 11329147
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human melanocytic naevi. I. Electron microscopy and 3-dimensional computer reconstruction of naevi and basement membrane zone from ultrathin serial sections.
    Lea PJ; Pawlowski A
    Acta Derm Venereol Suppl (Stockh); 1986; 127():5-15. PubMed ID: 3468728
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of claudin-1 expression in tumor-associated vessels correlates with acquisition of metastatic phenotype in melanocytic neoplasms.
    Cohn ML; Goncharuk VN; Diwan AH; Zhang PS; Shen SS; Prieto VG
    J Cutan Pathol; 2005 Sep; 32(8):533-6. PubMed ID: 16115050
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Melanoma biomarker expression in melanocytic tumor progression: a tissue microarray study.
    Nazarian RM; Prieto VG; Elder DE; Duncan LM
    J Cutan Pathol; 2010 Apr; 37 Suppl 1():41-7. PubMed ID: 20482674
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of gp100, MART-1, tyrosinase, and S100 in paraffin-embedded primary melanomas and locoregional, lymph node, and visceral metastases: implications for diagnosis and immunotherapy. A study conducted by the EORTC Melanoma Cooperative Group.
    de Vries TJ; Smeets M; de Graaf R; Hou-Jensen K; Bröcker EB; Renard N; Eggermont AM; van Muijen GN; Ruiter DJ
    J Pathol; 2001 Jan; 193(1):13-20. PubMed ID: 11169510
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recombinant gamma-interferon induces changes in expression and shedding of antigens associated with normal human melanocytes, nevus cells, and primary and metastatic melanoma cells.
    Herlyn M; Guerry D; Koprowski H
    J Immunol; 1985 Jun; 134(6):4226-30. PubMed ID: 2985706
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Equine skin tumours in 20 horses resembling three variants of human melanocytic naevi.
    Schöniger S; Summers BA
    Vet Dermatol; 2009 Jun; 20(3):165-73. PubMed ID: 19374725
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A subgroup of melanocytic nevi on the distal lower extremity (ankle) shares features of acral nevi, dysplastic nevi, and melanoma in situ: a potential misdiagnosis of melanoma in situ.
    Khalifeh I; Taraif S; Reed JA; Lazar AF; Diwan AH; Prieto VG
    Am J Surg Pathol; 2007 Jul; 31(7):1130-6. PubMed ID: 17592281
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of c-kit (CD117) in Spitz nevus and malignant melanoma.
    Isabel Zhu Y; Fitzpatrick JE
    J Cutan Pathol; 2006 Jan; 33(1):33-7. PubMed ID: 16441409
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclin D1 expression in melanocytic lesions of the skin.
    Ramirez JA; Guitart J; Rao MS; Diaz LK
    Ann Diagn Pathol; 2005 Aug; 9(4):185-8. PubMed ID: 16084449
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overexpression of Lerk-5/Eplg5 messenger RNA: a novel marker for increased tumorigenicity and metastatic potential in human malignant melanomas.
    Vogt T; Stolz W; Welsh J; Jung B; Kerbel RS; Kobayashi H; Landthaler M; McClelland M
    Clin Cancer Res; 1998 Mar; 4(3):791-7. PubMed ID: 9533549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of the c-met proto-oncogene product in normal skin and tumours of melanocytic origin.
    Saitoh K; Takahashi H; Sawada N; Parsons PG
    J Pathol; 1994 Nov; 174(3):191-9. PubMed ID: 7823252
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [An immunocytochemical investigation of antigen expression by skin melanoma cells cultured for vaccine production].
    Moiseenko VM; Danilova AB; Danilov AO; Turkevich EA; Baldueva IA; Matsko DE
    Vopr Onkol; 2008; 54(3):303-14. PubMed ID: 18652234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.